Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. It operates through three segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The company offers oncology medicines, including anlotinib hydrochloride capsules under Focus V brand, penpulimab injection under Annike brand, efbemalenograstin alfa injection under Yilishu brand, benmelstobart injection...
Industry: Biotechnology
Sector: Healthcare
Phone: 852 2802 9886
Address:
Unit 09, Office Tower, 41st Floor, Room 4109 Convention Plaza 1 Harbour Road, Wan Chai, Hong Kong
